about
Research recommendations for selected IARC-classified agentsSerum oncoproteins and growth factors in asbestosis and silicosis patientsA study of occupational exposure to antineoplastic drugs and fetal loss in nursesp53 autoantibodies predict subsequent development of cancerSerum growth factors in asbestosis patientsIARC monographs: 40 years of evaluating carcinogenic hazards to humansNew common variants affecting susceptibility to basal cell carcinomaMolecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarraySingle nucleotide polymorphisms (SNPs) are inherited from parents and they measure heritable eventsMorphological types of breast cancer in family members and multiple primary tumours: is morphology genetically determined?TP53-binding protein variants and breast cancer risk: a case-control studyCytogenetic markers, DNA single-strand breaks, urinary metabolites, and DNA repair rates in styrene-exposed lamination workersSomatic mutations in exocrine pancreatic tumors: association with patient survivalARLTS1 variants and melanoma riskAssociations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancerIncidence differences for gallbladder cancer between occupational groups suggest an etiological role for alcoholThe GH1/IGF-1 axis polymorphisms and their impact on breast cancer developmentPedigree based DNA sequencing pipeline for germline genomes of cancer familiesThe 9p21.3 risk of childhood acute lymphoblastic leukaemia is explained by a rare high-impact variant in CDKN2AThe CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myelomaTERT promoter mutations: a novel independent prognostic factor in primary glioblastomasCorrespondence: SEMA4A variation and risk of colorectal cancerRe: Role of the oxidative DNA damage repair gene OGG1 in colorectal tumorigenesisAssociation between TAS2R38 gene polymorphisms and colorectal cancer risk: a case-control study in two independent populations of Caucasian originVariation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotypeGermline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinomaCommon variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma riskVariation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphomaCommon variation at 3p22.1 and 7p15.3 influences multiple myeloma riskA genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)Chromosome 7p11.2 (EGFR) variation influences glioma riskGenome-wide association study on differentiated thyroid cancerSubsequent brain tumors in patients with autoimmune diseaseFamilial risk of urological cancers: data for clinical counseling.Familial risk of cancer: data for clinical counseling and cancer genetics.Incidence and survival in non-hereditary amyloidosis in SwedenGenetic variants in hormone-related genes and risk of breast cancer.Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study.Incidence of multiple primary malignancies among patients with bone cancers in Sweden.B-RAF and N-RAS mutations are preserved during short time in vitro propagation and differentially impact prognosis.
P50
Q23912511-A2FC0835-30BC-42C4-9F7F-9E20696B59B2Q23919355-5F1260CB-15CB-45A8-A13C-C37799154E90Q23921339-298999B0-C8E8-4607-9ACD-916672E551CFQ23924072-50956E83-802B-446D-AE4F-55BB98872A46Q23924074-BD8504C3-4654-4592-9768-B2E7E1723248Q24288812-EFB6643A-99F2-4BA6-A255-B03D426B6D99Q24615109-063766CE-B336-46B4-981B-56C5C999FCDFQ24650855-816990DD-5172-4839-A079-8682AF47A9ACQ24795928-16390D84-19C5-4870-B80B-3915E610395DQ24796391-2214A2D3-4883-428D-9CE2-BD2641AB23D7Q24810703-45311D7D-D877-4EB6-AE70-D6AC63D2E149Q24812594-9CF78EB7-07B1-466B-A4F6-4436485655C6Q27852155-50642312-4FD8-458C-AFB1-DBB6DEA346C4Q28237116-8697195C-7D4B-483B-944A-2E7FFD341093Q28240593-77C6828D-2DEC-476A-A060-BF96349D3527Q28242716-E9044F61-1980-496A-8406-97E854B4AC0CQ28272141-0407D21A-CA1C-4DEF-BB6F-3AF15B0A0F4DQ28386134-35B1BE2D-85B2-4A9B-8A6B-FAF6DC2D16D8Q28391081-EF113254-9D42-41ED-B79F-14DBAC6A5F1AQ28391289-DA78E10A-19DE-48F3-99B3-232A4CB979DCQ28397245-0DC80D0D-B653-484C-BCF3-AE18D435D7A5Q28602609-499799C4-230B-4512-9702-1B1A24643EC0Q28606428-8DBB9D86-DA93-415A-8880-F94D3AF01E00Q28744022-E358A8D1-B42F-4FC7-BD69-449B38BCBCD9Q28943255-EF46851A-3097-474D-8888-9822A4ED9CD9Q28943323-5AF95751-BF2C-48BE-8AE2-80E366E8E8C2Q28943335-C17B0EE7-D6BC-4657-A75B-A1207CFDD9C2Q28943378-8B6AB272-35BD-46C2-A4AE-E627DD0CEBE9Q28943395-AEDD4FB0-82C2-4FA3-ADF1-72E0BB7AE9D2Q28943455-35974A4D-DE47-4F8F-958E-CA0BF66F0F1CQ28943530-963B7B34-F571-46C9-9255-2DCA074EAB35Q28943543-6AFF7F6A-ED7D-4A62-883D-A658152FADB2Q30432018-B0B3848A-A5ED-4125-A808-D3F0BF3B5D57Q30884117-C1935DA3-E34F-432B-A1EB-F1EB38D3E9F3Q30884218-3D0000BF-6D22-490F-AD21-09C43F308711Q31106882-C50E09DC-3412-4305-B4D3-A5D10C03694EQ31126135-D5A98043-DE25-4B68-AE26-82FFCB53F1F1Q33263818-6186A200-A6B1-46C9-935B-1942767E2485Q33272608-1ABC35C0-E9B2-4893-BF89-1EB8A7A04518Q33274670-AFD29822-2A45-48C7-A434-7122309FE081
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kari Hemminki
@ast
Kari Hemminki
@en
Kari Hemminki
@es
Kari Hemminki
@nl
type
label
Kari Hemminki
@ast
Kari Hemminki
@en
Kari Hemminki
@es
Kari Hemminki
@nl
prefLabel
Kari Hemminki
@ast
Kari Hemminki
@en
Kari Hemminki
@es
Kari Hemminki
@nl
P106
P21
P31
P496
0000-0002-2769-3316